Your session is about to expire
← Back to Search
Insulin Pump
Sensor Augmented Pump Therapy for Cystic Fibrosis
N/A
Waitlist Available
Led By Christine Chan, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours of admission
Awards & highlights
No Placebo-Only Group
Summary
This research proposes a pilot study using the combination of continuous glucose monitor (CGM) and insulin pump therapy, also known as sensor augmented pump (SAP) therapy, for cystic fibrosis related diabetes (CFRD) management in the inpatient setting, with the aim of improving glycemic control.
Eligible Conditions
- Cystic Fibrosis
- CF exacerbation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 24 hours of admission
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours of admission
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Differences in CGM percent time over 140 mg/dl
Secondary study objectives
Change in Pulmonary Function
Circulatory markers of inflammation
Statstrip glucose
+1 moreOther study objectives
beta-cell function
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard of Care and CGMExperimental Treatment1 Intervention
Group II: Insulin Pump and CGMExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sensor Augmented Pump Therapy
2016
N/A
~110
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,806 Previous Clinical Trials
2,822,899 Total Patients Enrolled
18 Trials studying Cystic Fibrosis
982 Patients Enrolled for Cystic Fibrosis
Cystic Fibrosis FoundationOTHER
197 Previous Clinical Trials
37,569 Total Patients Enrolled
190 Trials studying Cystic Fibrosis
34,672 Patients Enrolled for Cystic Fibrosis
Christine Chan, MDPrincipal Investigatorchristinel.chan@childrenscolorado.org
Share this study with friends
Copy Link
Messenger